Also trades as: BDMS.BK (SET) · $vol 40M · BDUUY (OTC) · $vol 0M · BDULF (OTC) · $vol 0M · BDUUF (OTC) · $vol 0M
BDMS-R.BK SET
Bangkok Dusit Medical Services Public Company Limited
1W: -5.5%
1M: -5.7%
3M: -3.0%
YTD: -8.6%
1Y: -15.2%
3Y: -27.4%
5Y: -6.3%
฿19.00 ($0.57)
+0.00 (+0.00%)
Weekly Expected Move ±3.2%
฿18
฿18
฿19
฿20
฿20
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Balance Sheet Trends
Total Assets
$158.0B
+4.3% ▲
5Y CAGR: +3.0%
Total Liabilities
$48.0B
+0.8% ▲
5Y CAGR: +1.5%
Shareholders Equity
$105.9B
+5.9% ▲
5Y CAGR: +3.8%
Cash & Investments
$7.2B
-16.9% ▼
5Y CAGR: -19.1%
Total Debt
$25.1B
+36.7% ▲
5Y CAGR: +0.7%
Net Debt
$18.8B
+70.7% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $10.9B | $12.7B | $7.8B | $7.4B | $6.3B |
| Short-Term Investments | $1.7B | $2.3B | $1.7B | $1.3B | $900M |
| Cash & ST Investments | $12.7B | $15.0B | $9.5B | $8.7B | $7.2B |
| Net Receivables | $8.6B | $10.2B | $11.3B | $12.0B | $12.0B |
| Inventory | $2.0B | $2.2B | $2.4B | $2.6B | $3.4B |
| Other Current Assets | $873M | $386M | $73M | $95M | $459M |
| Total Current Assets | $24.4B | $27.8B | $23.5B | $23.7B | $23.1B |
| Property, Plant & Equip. | $82.6B | $91.5B | $97.3B | $104.0B | $109.5B |
| Goodwill & Intangibles | $18.8B | $19.2B | $19.4B | $19.8B | $20.3B |
| Long-Term Investments | $1.5B | $2.0B | $2.1B | $2.5B | $3.7B |
| Other Non-Current Assets | $1.1B | $1.0B | $1.2B | $1.2B | $933M |
| Total Non-Current Assets | $104.1B | $113.7B | $120.1B | $127.9B | $134.9B |
| Total Assets | $128.5B | $141.5B | $143.6B | $151.5B | $158.0B |
| — Liabilities — | |||||
| Accounts Payable | $3.6B | $4.2B | $4.5B | $4.9B | $5.1B |
| Short-Term Debt | $3.2B | $5.5B | $2.5B | $4.5B | $6.9B |
| Deferred Revenue | $170M | $183M | $191M | $190M | $190M |
| Other Current Liabilities | $1.6B | $948M | $1.0B | $1.2B | $10.1B |
| Total Current Liabilities | $15.9B | $20.6B | $18.4B | $22.0B | $23.6B |
| Long-Term Debt | $12.5B | $10.5B | $8.0B | $6.0B | $10.6B |
| Other Non-Current Liab. | $5.6B | $5.6B | $6.3B | $7.5B | $1.2B |
| Total Non-Current Liabilities | $24.8B | $27.2B | $26.3B | $25.6B | $24.3B |
| Total Liabilities | $40.7B | $47.8B | $44.7B | $47.6B | $48.0B |
| — Equity — | |||||
| Common Stock | $1.6B | $1.6B | $1.6B | $1.6B | $1.6B |
| Retained Earnings | $42.8B | $47.8B | $51.8B | $56.3B | $56.0B |
| Accumulated OCI | $176M | $176M | $11.5B | $176M | $18.1B |
| Total Stockholders Equity | $83.8B | $89.9B | $95.2B | $100.0B | $105.9B |
| Total Liabilities & Equity | $128.5B | $141.5B | $143.6B | $151.5B | $158.0B |
| — Key Metrics — | |||||
| Total Debt | $18.8B | $23.6B | $18.1B | $18.4B | $25.1B |
| Net Debt | $7.9B | $10.9B | $10.3B | $11.0B | $18.8B |
| Total Investments | $3.2B | $4.3B | $3.8B | $3.8B | $4.6B |